HALO logo
halo search icon
Abeona Therapeutics, Inc.

US$5.32

Price Change Indicator
0.20 (3.91%)
Abeona Therapeutics, Inc.
ABEO · NAS

Abeona Therapeutics, Inc.

Start Trading ABEO for Free

US$5.32

Price Arrow0.20 (3.91%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapEMA 125 BreakupFakey Shakey - ShortFakey Shakey - Short (Realtime)HALO AllHALO Consensus Value+2
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Abeona Therapeutics, Inc. Overview

ABEO Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Very Weak

About ABEO

icon
icon

Telephone

1.646.813.4701

icon

Address

4th floor, 6555 Carnegie Avenue, Cleveland, OH 44103

Description

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

ABEO Price Chart

Key Stats

Market Cap

US$291.82M

PE

5.20

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 4 - 7.54

Trade Value (12mth)

US$1,639,951.00

1 week

-6.74%

1 month

-4.83%

YTD

-3.58%

1 year

-20.62%

All time high

50000.00

Key Fundamentals

EPS 3 yr Growth

-124.30%

EBITDA Margin

NaN%

Operating Cashflow

-$76m

Free Cash Flow Return

-66.00%

ROIC

61.50%

Interest Coverage

-23.00

Quick Ratio

6.70

Other Data

Shares Outstanding (Fully Diluted)

57m

HALO Sector

Healthcare

Next Company Report Date

24-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ABEO Announcements

Latest Announcements

DateAnnouncements
13 May 26
13 May 26
13 May 26
13 May 26
13 May 26

ABEO Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-2.53-1.551.34locklocklock
EPS (Fully Diluted)
 $locklocklocklock-2.53-1.551.01locklocklock
Growth
 %locklocklocklock54.238.7186.6locklocklock
PE
 XlocklocklocklockN/AN/A5.2locklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Abeona Therapeutics, Inc. (ABEO:NAS)?
Halo FAQ
The current share price of Abeona Therapeutics, Inc. (ABEO:NAS) is USD$5.32.
What is the 52-week high share price for Abeona Therapeutics, Inc. (ABEO:NAS)?
Halo FAQ
The 52-week high share price for Abeona Therapeutics, Inc. (ABEO:NAS) is USD$7.54.
What is the 52-week low share price for Abeona Therapeutics, Inc. (ABEO:NAS)?
Halo FAQ
The 52-week low share price for Abeona Therapeutics, Inc. (ABEO:NAS) is USD$4.00.
What is the dividend yield for Abeona Therapeutics, Inc. (ABEO:NAS)?
Halo FAQ
Abeona Therapeutics, Inc. (ABEO:NAS) does not pay a dividend.
What was Abeona Therapeutics, Inc. (ABEO:NAS) last dividend payment?
Halo FAQ
Abeona Therapeutics, Inc. (ABEO:NAS) does not pay a dividend.
What is the franking level for Abeona Therapeutics, Inc. (ABEO:NAS)?
Halo FAQ
Abeona Therapeutics, Inc. (ABEO:NAS) has a franking level of 0.00%.
In which sector is Abeona Therapeutics, Inc. (ABEO:NAS) classified?
Halo FAQ
Abeona Therapeutics, Inc. (ABEO:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Abeona Therapeutics, Inc. (ABEO:NAS)?
Halo FAQ
The current P/E ratio for Abeona Therapeutics, Inc. (ABEO:NAS) is 5.20.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial